Litigation Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
✉ Email this page to a colleague
UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-07-16 |
| Court | District Court, D. Vermont | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Christina R |
| Jury Demand | Referred To | ||
| Patents | 10,130,589; 10,350,174; 9,925,150 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB, Inc. v. Mylan Technologies, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-05-08 | 95 | Order re: Claim Construction Brief | infringed two patents, United States patent No. 10,130,589 B2 (the "'589 patent") and United…States patent No. 10,350,174 B2 (the "' 174 patent") (collectively, the "patents-in-suit…both continuations of the same parent patent, United States patent No. 9,925,150, and have the same specifications…#39;5 89 patent and "[a] stable solid dispersion" in claim 1 of the ' 174 patent. II. …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
